Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Jan. 25, 2019 |
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
|
| Common stock, par value | $ 0.01 | $ 0.01 | ||
| Received net proceeds | $ 6,015 | |||
| Underwriting Agreement [Member] | ||||
| Aggregate of shares issued | 9,333,334 | |||
| Common stock, par value | $ 0.01 | |||
| Options granted | 1,400,000 | |||
| Common stock price, per share | $ 0.75 | |||
| Effective price per share | $ 0.6975 | |||
| Received net proceeds | $ 6,100 | |||
| X | ||||||||||
- Definition Effective price per share. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|